Horizon Pharma PLC

Find Ratings Reports
HZNP : NASDAQ : Health Care
$18.73 | %
Today's Range: 0.00 - 0.00
Avg. Daily Volume: 4,022,300
07/25/16 - 4:00 PM ET

Financial Analysis


HORIZON PHARMA PLC's gross profit margin for the first quarter of its fiscal year 2016 is essentially unchanged when compared to the same period a year ago. Even though sales increased, the net income has decreased, representing a decrease to the bottom line. HORIZON PHARMA PLC has strong liquidity. Currently, the Quick Ratio is 1.53 which shows the ability to cover short-term cash needs. The company's liquidity has decreased from the same period last year.

At the same time, stockholders' equity ("net worth") has greatly increased by 87.79% from the same quarter last year. The key liquidity measurements indicate that the company is unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q1 FY16 Q1 FY15
Net Sales ($mil)204.69113.14
EBITDA ($mil)41.928.91
EBIT ($mil)-8.7410.57
Net Income ($mil)-45.41-19.55


Balance Sheet Q1 FY16 Q1 FY15
Cash & Equiv. ($mil)388.63544.81
Total Assets ($mil)3205.491527.3
Total Debt ($mil)1140.18589.84
Equity ($mil)1291.97687.96


Profitability Q1 FY16 Q1 FY15
Gross Profit Margin90.1892.85
EBITDA Margin20.4625.54
Operating Margin-4.279.34
Sales Turnover0.260.23
Return on Assets0.42-5.03
Return on Equity1.05-11.17
Debt Q1 FY16 Q1 FY15
Current Ratio1.983.75
Debt/Capital0.470.46
Interest Expense19.4610.03
Interest Coverage-0.451.05


Share Data Q1 FY16 Q1 FY15
Shares outstanding (mil)160.25133.29
Div / share0.00.0
EPS-0.28-0.16
Book value / share8.065.16
Institutional Own % n/a n/a
Avg Daily Volume4063498.04967433.0

Valuation


SELL. HORIZON PHARMA PLC's P/E ratio indicates a significant premium compared to an average of 45.39 for the Pharmaceuticals industry and a significant premium compared to the S&P 500 average of 25.05. To use another comparison, its price-to-book ratio of 2.37 indicates a discount versus the S&P 500 average of 2.81 and a significant discount versus the industry average of 8.86. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
HZNP 211.89 Peers 45.39   HZNP 9.15 Peers 31.23

Premium. A higher P/E ratio than its peers can signify a more expensive stock or higher growth expectations.

HZNP is trading at a significant premium to its peers.

 

Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

HZNP is trading at a significant discount to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
HZNP 7.22 Peers 16.56   HZNP 0.24 Peers 0.58

Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations.

HZNP is trading at a significant discount to its peers.

 

Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

HZNP trades at a significant discount to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
HZNP 2.37 Peers 8.86   HZNP 111.39 Peers -19.27

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

HZNP is trading at a significant discount to its peers.

 

Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

HZNP is expected to have an earnings growth rate that significantly exceeds its peers.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
HZNP 3.60 Peers 23.05   HZNP 136.92 Peers 6.33

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

HZNP is trading at a significant discount to its industry on this measurement.

 

Higher. A sales growth rate that exceeds the industry implies that a company is gaining market share.

HZNP has a sales growth rate that significantly exceeds its peers.

 

 

Latest Stock Upgrades/Downgrades